Navigating the landscape of clinical genetic testing: insights and challenges in rare disease diagnostics

키워드

참고문헌 (61)

1. Boycott KM, "Rare-disease genetics in the era of next-generation sequencing : discovery to translation", Nat Rev Genet, 14, pp.681~691 (2013)
2. "Orphanet reports series/procedures" (2022)[URL]
3. Nguengang Wakap S, "Estimating cumulative point prevalence of rare diseases : analysis of the Orphanet database", Eur J Hum Genet, 28, pp.165~173 (2020)
4. "RARE disease facts" (2020)[URL]
5. Lalonde E, "Genomic diagnosis for pediatric disorders : revolution and evolution", Front Pediatr, 8, pp.373~ (2020)
6. Yunis JJ, "Mid-prophase human chromosomes : the attainment of 2000bands", Hum Genet, 56, pp.293~298 (1981)
7. Kallioniemi OP, "Comparative genomic hybridization : a rapid new method for detecting and mapping DNA amplification in tumors", Semin Cancer Biol, 4, pp.41~46 (1993)
8. Solinas-Toldo S, "Matrix-based comparative genomic hybridization : biochips to screen for genomic imbalances", Genes Chromosomes Cancer, 20, pp.399~407 (1997)
9. Albertson DG, "Genomic microarrays in human genetic disease and cancer", Hum Mol Genet, 12(Spec No 2), pp.R145~52 (2003)
10. Ahn JW, "Array CGH as a first line diagnostic test in place of karyotyping for postnatal referrals : results from four years’ clinical application for over 8, 700 patients", Mol Cytogenet, 6, pp.16~ (2013)
11. Battaglia A, "Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features", Eur J Paediatr Neurol, 17, pp.589~599 (2013)
12. Stankiewicz P, "Structural variation in the human genome and its role in disease", Annu Rev Med, 61, pp.437~455 (2010)
13. Vissers LE, "Genomic microarrays in mental retardation : from copy number variation to gene, from research to diagnosis", J Med Genet, 47, pp.289~297 (2010)
14. Rudkin GT, "High resolution detection of DNA-RNA hybrids in situ by indirect immunofluorescence", Nature, 265, pp.472~473 (1977)
15. Iqbal MA, "Use of FISH technique in the diagnosis of chromosomal syndromes", East Mediterr Health J, 5, pp.1218~1224 (1999)
16. Sanger F, "DNA sequencing with chain-terminating inhibitors", Proc Natl Acad Sci U S A, 74, pp.5463~5467 (1977)
17. Goossens M, "The amplification of nucleotide sequences by PCR and the new technics for molecular diagnosis", Reprod Nutr Dev, 1(Suppl 1), pp.117s~124s (1990)
18. Ben-Ezra JM, "Amplification methods in the molecular diagnosis of genetic diseases", Clin Lab Med, 15, pp.795~815 (1995)
19. Erlich HA, "Genetic analysis using the polymerase chain reaction", Annu Rev Genet, 26, pp.479~506 (1992)
20. Schouten JP, "Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification", Nucleic Acids Res, 30, pp.e57~ (2002)
21. Stuppia L, "Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases", Int J Mol Sci, 13, pp.3245~3276 (2012)
22. Borst M, "DNA isolation and Southern analysis : a clinician's view", Am J Med Sci, 299, pp.356~360 (1990)
23. Southern EM, "Detection of specific sequences among DNA fragments separated by gel electrophoresis", J Mol Biol, 98, pp.503~517 (1975)
24. Reuter JA, "High-throughput sequencing technologies", Mol Cell, 58, pp.586~597 (2015)
25. Pettersson E, "Generations of sequencing technologies", Genomics, 93, pp.105~111 (2009)
26. Fernandez-Marmiesse A, "NGS technologies as a turning point in rare disease research, diagnosis and treatment", Curr Med Chem, 25, pp.404~432 (2018)
27. Chung CC, "Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations", Genet Med, 25, pp.100896~ (2023)
28. Jais JP, "X-linked Alport syndrome : natural history and genotype-phenotype correlations in girls and women belonging to 195 families : a"European Community Alport Syndrome Concerted Action"study", J Am Soc Nephrol, 14, pp.2603~2610 (2003)
29. Bekheirnia MR, "Genotype-phenotype correlation in X-linked Alport syndrome", J Am Soc Nephrol, 21, pp.876~883 (2010)
30. Rao AN, "Inborn errors of metabolism : review and data from a tertiary care center", Indian J Clin Biochem, 24, pp.215~222 (2009)
31. Kim MJ, "Rapid targeted sequencing using dried blood spot samples for patients with suspected actionable genetic diseases", Ann Lab Med, 43, pp.280~289 (2023)
32. Owen MJ, "Rapid sequencing-based diagnosis of thiamine metabolism dysfunction syndrome", N Engl J Med, 384, pp.2159~2161 (2021)
33. Wojcik MH, "Provision and availability of genomic medicine services in level IV neonatal intensive care units", Genet Med, 25, pp.100926~ (2023)
34. Incerti D, "Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases", Genet Med, 24, pp.109~118 (2022)
35. Runheim H, "The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders", Sci Rep, 13, pp.6904~ (2023)
36. Yeung A, "A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients", Genet Med, 22, pp.1986~1993 (2020)
37. Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
38. "ACGS best practice guidelines for variant classification in Rare Disease 2020" (2020)[URL]
39. Amendola LM, "Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium", Am J Hum Genet, 98, pp.1067~1076 (2016)
40. Inoue Y, "Need for revision of the ACMG", AMP guidelines for interpretation of X-linked variants, 2022, pp.11, 120~124
41. Patel MJ, "Disease-specific ACMG", AMP guidelines improve sequence variant interpretation for hearing loss, 2021, pp.23, 2208~2212
42. Strande NT, "Navigating the nuances of clinical sequence variant interpretation in Mendelian disease", Genet Med, 20, pp.918~926 (2018)
43. Gelb BD, "ClinGen’s RASopathy Expert Panel consensus methods for variant interpretation", Genet Med, 20, pp.1334~1345 (2018)
44. Savige J, "Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome : refining the ACMG criteria", Eur J Hum Genet, 29, pp.1186~1197 (2021)
45. Chen E, "Rates and classification of variants of uncertain significance in hereditary disease genetic testing", JAMA Netw Open, 6, pp.e2339571~ (2023)
46. Burke W, "The challenge of genetic variants of uncertain clinical significance : a narrative review", Ann Intern Med, 175, pp.994~1000 (2022)
47. Johnson B, "Systematic use of phenotype evidence in clinical genetic testing reduces the frequency of variants of uncertain significance", Am J Med Genet A, 188, pp.2642~2651 (2022)
48. Nykamp K, "Sherloc : a comprehensive refinement of the ACMG-AMP variant classification criteria", Genet Med, 19, pp.1105~1117 (2017)
49. Kingdom R, "Incomplete penetrance and variable expressivity : from clinical studies to population cohorts", Front Genet, 13, pp.920390~ (2022)
50. Rossetti S, "Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease", Kidney Int, 75, pp.848~855 (2009)
51. Benson PF, "GM1-generalized gangliosidosis variant with cardiomegaly", Postgrad Med J, 52, pp.159~165 (1976)
52. Arbisser AI, "Morquio-like syndrome with beta galactosidase deficiency and normal hexosamine sulfatase activity : mucopolysacchariodosis IVB", Am J Med Genet, 1, pp.195~205 (1977)
53. Vytopil M, "Frequent low penetrance mutations in the Lamin A", C gene, causing Emery Dreifuss muscular dystrophy, 2002, pp.12, 958~963
54. Burdon KP, "A novel mutation in the Connexin 46 gene causes autosomal dominant congenital cataract with incomplete penetrance", J Med Genet, 41, pp.e106~ (2004)
55. Shawky RM, "Reduced penetrance in human inherited disease", Egypt J Medl Hum Genet, 15, pp.103~111 (2014)
56. Pereira R, "Phenotypic variability and incomplete penetrance of spontaneous fractures in an inbred strain of transgenic mice expressing a mutated collagen gene(COL1A1)", J Clin Invest, 93, pp.1765~1769 (1994)
57. Van Dijk FS, "Osteogenesis imperfecta : clinical diagnosis, nomenclature and severity assessment", Am J Med Genet A, 164A, pp.1470~1481 (2014)
58. Ellingford JM, "Phenotype and genotype correlations in inherited retinal diseases: population-guided variant interpretation, variable expressivity and incomplete penetrance", Genes (Basel), 11, pp.1274~ (2020)
59. Vujic M, "Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD", J Am Soc Nephrol, 21, pp.1097~1102 (2010)
60. Stein Q, "Genetic counseling in kidney disease : a perspective", Kidney Med, 5, pp.100668~ (2023)
61. Burger J, "Hereditary spastic paraplegia caused by mutations in the SPG4 gene", Eur J Hum Genet, 8, pp.771~776 (2000)

관련 논문AI추천